Skylands Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,150
Closed -$561K 184
2017
Q1
$561K Sell
7,150
-15,150
-68% -$1.21M 0.08% 135
2016
Q4
$1.76M Buy
22,300
+500
+2% +$40.5K 0.27% 92
2016
Q3
$1.94M Buy
21,800
+3,250
+18% +$307K 0.3% 80
2016
Q2
$1.78M Buy
18,550
+3,650
+24% +$364K 0.29% 77
2016
Q1
$1.55M Sell
14,900
-1,500
-9% -$146K 0.25% 83
2015
Q4
$1.6M Hold
16,400
0.23% 98
2015
Q3
$1.58M Sell
16,400
-300
-2% -$31.5K 0.21% 101
2015
Q2
$1.75M Sell
16,700
-300
-2% -$30.7K 0.19% 115
2015
Q1
$1.75M Sell
17,000
-5,300
-24% -$536K 0.18% 108
2014
Q4
$2.15M Sell
22,300
-8,700
-28% -$767K 0.22% 90
2014
Q3
$2.47M Sell
31,000
-800
-3% -$63.1K 0.25% 95
2014
Q2
$2.4M Sell
31,800
-9,900
-24% -$748K 0.23% 103
2014
Q1
$3.12M Sell
41,700
-300
-0.7% -$21.2K 0.32% 75
2013
Q4
$3.01M Sell
42,000
-5,100
-11% -$328K 0.33% 71
2013
Q3
$2.67M Sell
47,100
-200
-0.4% -$11.9K 0.3% 77
2013
Q2
$2.71M Buy
+47,300
New +$2.74M 0.32% 70

Other funds holding CVS

Skylands Capital's CVS Position: Q2 2017 in Review

Skylands Capital sold out of CVS Health (CVS) in Q2 2017, closing a stake of 7,150 shares — an estimated $561K sold.

Skylands Capital first reported a position in CVS in Q2 2013 and held it in 16 quarters. The position peaked at $3.12M in Q1 2014. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • Skylands Capital reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
  • Skylands Capital sold 7,150 CVS Health shares in Q2 2017, an estimated $561K.
  • Skylands Capital first reported a position in CVS Health in Q2 2013 and held it in 16 quarters.
  • Skylands Capital's CVS Health position peaked at $3.12M in Q1 2014.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Skylands Capital's 13F filing for Q2 2017, filed 20 Jul 2017.